Endothelial Monocyte-Activating Polypeptide-II Is an Indicator of Severity and Mortality in COVID-19 Patients

Data for predicting the severity and mortality of coronavirus disease 2019 (COVID-19) are limited, and investigations are ongoing. Endothelial monocyte-activating protein II (EMAP-II) is a multifunctional polypeptide with pro-inflammatory properties. EMAP-II is a significant pathogenic component in...

Descripción completa

Detalles Bibliográficos
Autores principales: Saber, Manal Mohamed, Nomair, Azhar Mohamed, Osman, Ashraf M., Nomeir, Hanan Mohamed, Farag, Naglaa M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9784120/
https://www.ncbi.nlm.nih.gov/pubmed/36560587
http://dx.doi.org/10.3390/vaccines10122177

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9784120/
https://www.ncbi.nlm.nih.gov/pubmed/36560587
http://dx.doi.org/10.3390/vaccines10122177

Ejemplares similares